31 Stocks Moving In Thursday's Mid-Day Session
$ADBE
$ADGI
$AGFY
$AMBA
Computer Software: Prepackaged Software
Technology
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- Calliditas Therapeutics AB (NASDAQ:CALT) shares climbed 28.7% to $24.13 after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
- Stryve Foods, Inc. (NASDAQ:SNAX) climbed 23.8% to $4.16 following news of deals for the expansion of its domestic US distribution and product line penetration with Costco and Walmart.
- Adagio Therapeutics, Inc. (NASDAQ:ADGI) shares climbed 23.5% to $7.84. Traders circulated reiterated buy rating and $46 price target from Jefferies.
- Euro Tech Holdings Company Limited (NASDAQ:CLWT) jumped 20% to $3.5280.
- Mechel PAO (NYSE:MTL) gained 18.1% to $3.14.
- Assertio Holdings, Inc. (NASDAQ:ASRT) rose 17.6% to $1.5840 after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.
- Jowell Global Ltd. (NASDAQ:JWEL) gained 17.2% to $20.70. Jowell Global recently posted Q3 sales of $43.80 million.
- Zai Lab Limited (NASDAQ:ZLAB) jumped 17% to $64.04 after the company announced China has approved NUZYRA as a category 1 innovative drug for the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
- X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) gained 16% to $2.36. X4 Pharmaceuticals recently presented new clinical and scientific data at the 2021 ASH Annual Meeting.
- Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) jumped 15.6% to $41.07 after reporting new data and providing additional updates from ARCT-154 and ARCT-165 clinical trials.
- American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 14.1% to $1.7450 after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.
- Engine Gaming and Media, Inc. (NASDAQ:GAME) jumped 13.6% to $3.25.
- MoneyLion Inc. (NYSE:ML) gained 13% to $3.9150 as the company announced plans to acquire Even Financial for up to $440 million.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) rose 12.6% to $3.2301 after gaining over 4% on Wednesday.
- Doma Holdings Inc. (NYSE:DOMA) gained 11.3% to $5.49.
- CooTek (Cayman) Inc. (NYSE:CTK) rose 7.6% to $0.5197 after dropping more than 10% on Wednesday.
- HUTCHMED (China) Limited (NASDAQ:HCM) rose 6.6% to $34.00.
- Retail Value Inc. (NYSE:RVI) rose 5.1% to $6.37 after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.
Check out these big penny stock gainers and losers
Losers
- IronNet, Inc. (NASDAQ:IRNT) shares dipped 27% to $4.9680 after the company said Q3 sales results were lower year over year. Needham downgraded IronNet from Buy to Hold.
- Bakkt Holdings, Inc. (NASDAQ:BKKT) fell 24.5% to $10.39 after the company reported a mixed shelf offering.
- uniQure N.V. (NASDAQ:QURE) fell 22% to $22.44 after the company reported clinical update on first patients in Phase I/II clinical trial of AMT-130 gene therapy for the treatment of Huntington's disease.
- Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) dropped 18.3% to $2.2701. Quoin Pharma recently announced an exclusive distribution agreement with Orpharm LLC for QRX003.
- Danimer Scientific, Inc. (NYSE:DNMR) shares fell 16.5% to $8.81 after the company reported a proposed convertible senior notes offering.
- Regional Health Properties, Inc. (NYSE:RHE) dropped 14.4% to $5.74. Regional Health Props, last month, posted Q3 loss of $1.25 per share.
- Agrify Corporation (NASDAQ:AGFY) fell 13.7% to $10.85.
- Ensysce Biosciences, Inc. (NASDAQ:ENSC) dropped 10.4% to $3.6799. Ensysce Biosciences said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.
- East Stone Acquisition Corporation (NASDAQ:ESSC) dipped 10.1% to $13.70.
- Adobe Inc. (NASDAQ:ADBE) fell 8.6% to $575.88 after the company issued Q1 and FY22 EPS and sales guidance below analyst estimates.
- Galera Therapeutics, Inc. (NASDAQ:GRTX) fell 8% to $2.67.
- Ambarella, Inc. (NASDAQ:AMBA) fell 7.8% to $193.13.
- Doximity, Inc. (NASDAQ:DOCS) dropped 7.8% to $51.39.
